Sequential combination of high dose ARA-C (HiDAC) and asparaginase (ASP) for the treatment of advanced acute leukemia and lymphoma
- 1 January 1984
- journal article
- research article
- Published by Elsevier in Leukemia Research
- Vol. 8 (4) , 729-735
- https://doi.org/10.1016/0145-2126(84)90021-3
Abstract
No abstract availableKeywords
This publication has 8 references indexed in Scilit:
- High Dose Cytosine Arabinoside in the Management of Refractory Acute LeukaemiaScandinavian Journal of Haematology, 1982
- A PILOT-STUDY OF HIGH-DOSE 1-BETA-D-ARABINOFURANOSYLCYTOSINE FOR ACUTE-LEUKEMIA AND REFRACTORY LYMPHOMA - CLINICAL-RESPONSE AND PHARMACOLOGY1982
- High dose cytosine arabinoside (HDARAC) in refractory acute leukemiaCancer, 1979
- The mechanisms of lethal action of arabinosyl cytosine (araC) and arabinosyl adenine (araA)Cancer, 1977
- Drugs Five Years LaterAnnals of Internal Medicine, 1975
- Mechanisms of Resistance of Human Acute Leukaemia Cells to Cytosine ArabinosideBritish Journal of Haematology, 1974
- Studies on drug resistance—II. Kinase patterns in P815 neoplasms sensitive and resistant to 1-β-d-arabinofuranosylcytosineBiochemical Pharmacology, 1970